CSIMarket
 

Nu med Plus Inc   (NUMD)

Nu Med Plus Inc 's

Competitiveness




 

NUMD Sales vs. its Competitors Q2 2026



Comparing the current results to its competitors, Nu Med Plus Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 5.71 %, recorded in the same quarter.

List of NUMD Competitors





Revenue Growth Comparisons




Net Income Comparison


Nu med Plus Inc achieved net profit of $0.02 millions compared to a net loss of $-0.01 millions recorded in the same quarter a year ago.

<<  NUMD Stock Performance Comparisons


Nu Med Plus Inc 's Comment on Competition and Industry Peers


NU-MED operates in the nitric oxide market alongside competitors such as Mallinckrodt Inc., which holds the only FDA-approved nitric oxide delivery system (INOMAX) for treating persistent pulmonary hypertension in newborns. Mallinckrodt has also submitted additional medical uses of nitric oxide for FDA approval and is conducting clinical trials for cystic fibrosis and chronic obstructive pulmonary disease treatments. NU-MED recognizes that competitors, individually or with partners, may possess greater financial, technical, and human resources, as well as more experience in product development, regulatory approvals, and commercialization. This may provide them advantages in obtaining approvals and achieving market acceptance. NU-MED anticipates increasing competition as new drugs and advanced technologies are developed.



*Market share is calculated based on total revenue.





Publicly Traded Peers of Nu med Plus Inc




Aurora Cannabis Inc
Share Performance



-11.98%
This Year



Aurora Cannabis Inc
Profile

Aurora Cannabis Inc operates as a vertically integrated cannabis company, controlling every aspect of the supply chain from cultivation to distribution. They focus on producing and selling medical and recreational cannabis products globally. This business model allows them to have greater control over product quality, streamline operations, and capitalize on the growing market for cannabis.

More about Aurora Cannabis Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ - mill. $ 369.528 mill. $ -104.148 mill.


Canopy Growth Corporation
Share Performance



-21.18%
This Year



Canopy Growth Corporation
Profile

Canopy Growth Corporation's business model revolves around being a leading producer and distributor of cannabis products, including both medicinal and recreational cannabis. The company focuses on cultivating, processing, and manufacturing various cannabis-based products, such as dried flowers, oils, and edibles. Canopy Growth Corporation also aims to expand its market presence through strategic partnerships and acquisitions, both domestically and internationally.

More about Canopy Growth Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 396.084 mill. $ 323.171 mill. $ -180.151 mill.


Vici Properties Inc
Share Performance



-24.26%
One Year



Vici Properties Inc
Profile

Vici Properties Inc. operates as a real estate investment trust (REIT) that owns and leases out premier entertainment, gaming, and hospitality destinations across the United States. The company generates revenue by leasing its properties to leading operators in the gaming and hospitality industry under long-term triple-net lease agreements, thereby providing stable and predictable cash flows. As a landlord, Vici Properties Inc. focuses on maximizing shareholder value through strategic acquisitions, efficient property management, and strong tenant relationships.

More about Vici Properties Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 27,315.878 mill. $ 4,097.604 mill. $ 2,809.176 mill.

Sources: Nu med Plus Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nu med Plus Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.